TRACEY RZEPKA: Open Payments
NPI 1588086920 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 15 payments from 10 companies in 2025. Trend: 2023 $719 · 2024 $547 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $247 |
| Axsome Therapeutics, Inc. | 2 | $245 |
| Lundbeck LLC | 2 | $219 |
| Lilly USA, LLC | 2 | $193 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| TMS NeuroHealth Centers Inc. | 2 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| Pulmonx Corporation | 1 | $110 |
| ViiV Healthcare Company | 1 | $23 |
Products named: CAPLYTA, Auvelity, AMVUTTRA, VOQUEZNA, VYEPTI, TMS NeuroHealth Centers Inc., AIRSUPRA, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
